May 7, 2023
Katie Shen
Share
https://pubmed.ncbi.nlm.nih.gov/36515952/
Should HBV genotype be considered in determining who to surveil for HCC?
March 21, 2022
A Phase 3 Biomarker Validation of GALAD for the Detection of Hepatocellular Carcinoma in Cirrhosis
March 9, 2026
Semaglutide Improves Histology in MASH: Phase 3 ESSENCE Trial
January 20, 2026